611 related articles for article (PubMed ID: 35094076)
1. The Metabolic Role and Therapeutic Potential of the Microbiome.
Olofsson LE; Bäckhed F
Endocr Rev; 2022 Sep; 43(5):907-926. PubMed ID: 35094076
[TBL] [Abstract][Full Text] [Related]
2. The interaction between microbiome and host central nervous system: the gut-brain axis as a potential new therapeutic target in the treatment of obesity and cardiometabolic disease.
Wijdeveld M; Nieuwdorp M; IJzerman R
Expert Opin Ther Targets; 2020 Jul; 24(7):639-653. PubMed ID: 32441559
[TBL] [Abstract][Full Text] [Related]
3. Diagnostics and therapeutic implications of gut microbiota alterations in cardiometabolic diseases.
Schiattarella GG; Sannino A; Esposito G; Perrino C
Trends Cardiovasc Med; 2019 Apr; 29(3):141-147. PubMed ID: 30126689
[TBL] [Abstract][Full Text] [Related]
4. Fecal Microbial Transplantation and Its Potential Application in Cardiometabolic Syndrome.
Leshem A; Horesh N; Elinav E
Front Immunol; 2019; 10():1341. PubMed ID: 31258528
[TBL] [Abstract][Full Text] [Related]
5. Implication of gut microbiota metabolites in cardiovascular and metabolic diseases.
Brial F; Le Lay A; Dumas ME; Gauguier D
Cell Mol Life Sci; 2018 Nov; 75(21):3977-3990. PubMed ID: 30101405
[TBL] [Abstract][Full Text] [Related]
6. Human microbiome and cardiovascular diseases.
Alam MJ; Puppala V; Uppulapu SK; Das B; Banerjee SK
Prog Mol Biol Transl Sci; 2022; 192(1):231-279. PubMed ID: 36280321
[TBL] [Abstract][Full Text] [Related]
7. Role of the Gut Microbiome in Diabetes and Cardiovascular Diseases Including Restoration and Targeting Approaches- A Review.
Alka Ahuja ; Saraswathy Mp ; Nandakumar S ; Prakash F A; Kn G; Um D
Drug Metab Bioanal Lett; 2022; 15(3):133-149. PubMed ID: 36508273
[TBL] [Abstract][Full Text] [Related]
8. Targeting the Gut Microbiome to Treat Cardiometabolic Disease.
Theofilis P; Vlachakis PK; Oikonomou E; Tsioufis K; Tousoulis D
Curr Atheroscler Rep; 2024 Feb; 26(2):25-34. PubMed ID: 38180642
[TBL] [Abstract][Full Text] [Related]
9. The gut microbiome, diet, and links to cardiometabolic and chronic disorders.
Aron-Wisnewsky J; Clément K
Nat Rev Nephrol; 2016 Mar; 12(3):169-81. PubMed ID: 26616538
[TBL] [Abstract][Full Text] [Related]
10. The gut microbiota and metabolic disease: current understanding and future perspectives.
Arora T; Bäckhed F
J Intern Med; 2016 Oct; 280(4):339-49. PubMed ID: 27071815
[TBL] [Abstract][Full Text] [Related]
11. Impact of the gut microbiota on inflammation, obesity, and metabolic disease.
Boulangé CL; Neves AL; Chilloux J; Nicholson JK; Dumas ME
Genome Med; 2016 Apr; 8(1):42. PubMed ID: 27098727
[TBL] [Abstract][Full Text] [Related]
12. Gut Microbiota in Cardiovascular Health and Disease.
Tang WH; Kitai T; Hazen SL
Circ Res; 2017 Mar; 120(7):1183-1196. PubMed ID: 28360349
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiome, endocrine control of gut barrier function and metabolic diseases.
Régnier M; Van Hul M; Knauf C; Cani PD
J Endocrinol; 2021 Feb; 248(2):R67-R82. PubMed ID: 33295880
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Gut Microbiota, Microbial Metabolites and Interaction with Polyphenol in Host Immunometabolism.
Man AWC; Zhou Y; Xia N; Li H
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33036205
[TBL] [Abstract][Full Text] [Related]
15. Modulatory role of gut microbiota in cholesterol and glucose metabolism: Potential implications for atherosclerotic cardiovascular disease.
Roessler J; Leistner DM; Landmesser U; Haghikia A
Atherosclerosis; 2022 Oct; 359():1-12. PubMed ID: 36126379
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota and Microbial Metabolism in Early Risk of Cardiometabolic Disease.
Gabriel CL; Ferguson JF
Circ Res; 2023 Jun; 132(12):1674-1691. PubMed ID: 37289901
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbial Associations to Plasma Metabolites Linked to Cardiovascular Phenotypes and Risk.
Kurilshikov A; van den Munckhof ICL; Chen L; Bonder MJ; Schraa K; Rutten JHW; Riksen NP; de Graaf J; Oosting M; Sanna S; Joosten LAB; van der Graaf M; Brand T; Koonen DPY; van Faassen M; ; Slagboom PE; Xavier RJ; Kuipers F; Hofker MH; Wijmenga C; Netea MG; Zhernakova A; Fu J
Circ Res; 2019 Jun; 124(12):1808-1820. PubMed ID: 30971183
[TBL] [Abstract][Full Text] [Related]
18. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
[TBL] [Abstract][Full Text] [Related]
19. The human gut microbiome - a new and exciting avenue in cardiovascular drug discovery.
Du Y; Li X; Su C; Wang L; Jiang J; Hong B
Expert Opin Drug Discov; 2019 Oct; 14(10):1037-1052. PubMed ID: 31315489
[No Abstract] [Full Text] [Related]
20. Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health.
Chambers ES; Preston T; Frost G; Morrison DJ
Curr Nutr Rep; 2018 Dec; 7(4):198-206. PubMed ID: 30264354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
